Carfilzomib and Proteinuria: Potential Interference or Iatrogeny?

J Appl Lab Med. 2024 Sep 3;9(5):1074-1076. doi: 10.1093/jalm/jfae040.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Humans
  • Male
  • Multiple Myeloma* / diagnosis
  • Multiple Myeloma* / drug therapy
  • Oligopeptides* / administration & dosage
  • Oligopeptides* / adverse effects
  • Proteinuria* / chemically induced
  • Proteinuria* / diagnosis
  • Proteinuria* / etiology
  • Proteinuria* / urine

Substances

  • carfilzomib
  • Oligopeptides